Gradient Investments’s IGC Pharma IGC Stock Holding History

Gradient Investments’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,000	Closed	-$1K	–	791
2016 Q4	$1K	Hold	2,000	–	–	﹤0.01%	674
2016 Q3	$1K	Hold	2,000	–	–	﹤0.01%	652
2016 Q2	$1K	Hold	2,000	–	–	﹤0.01%	655
2016 Q1	$1K	Buy	+2,000	New	+$606	﹤0.01%	665

Other funds holding IGC

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Gradient Investments's IGC Position: Q1 2017 in Review

Gradient Investments sold out of IGC Pharma (IGC) in Q1 2017, closing a stake of 2,000 shares — an estimated $1K sold.

Gradient Investments first reported a position in IGC in Q1 2016 and held it in 4 quarters. The position peaked at $1K in Q4 2016. 6 funds tracked by Wall St. Rank hold IGC as of Q1 2017.

Gradient Investments reported no remaining IGC Pharma position as of Q1 2017 after selling out during the quarter.
Gradient Investments sold 2,000 IGC Pharma shares in Q1 2017, an estimated $1K.
Gradient Investments first reported a position in IGC Pharma in Q1 2016 and held it in 4 quarters.
Gradient Investments's IGC Pharma position peaked at $1K in Q4 2016.
6 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2017.

Based on Gradient Investments's 13F filing for Q1 2017, filed 12 Apr 2017.